[ad_1]
Dr. Cheng will assist pharmaceutical purchasers in well being economics and outcomes analysis (HEOR) and epidemiology to develop methods for product differentiation and entry; and to implement analytic strategies to generate real-world proof to exhibit unmet wants, comparative effectiveness and long-term security of therapeutic merchandise. Dr. Cheng additionally gives professional assist and testimony in disputes that require the evaluation of scientific information.
Most not too long ago, Dr. Cheng was a vp at a number one well being care consulting agency, the place she spent greater than a decade advising pharmaceutical firms on information analytics for product improvement, regulatory approval and market adoption. Her expertise consists of pure historical past research, financial and predictive modeling, real-world proof improvement, surveys, individualized drugs, affected person resolution aids and post-approval and post-authorization security research for the U.S. Meals and Drug Administration (FDA) and European Medicines Company (EMA). Her work spans a number of therapeutic areas, together with uncommon and ultra-rare ailments. She additionally makes a speciality of making use of superior methodologies to handle complicated well being care analysis challenges, together with using machine-learning methods to determine value clusters and predict prognosis patterns and illness states in affected person populations.
“Wendy’s information of superior epidemiologic analysis strategies and instruments similar to machine studying is at the forefront within the discipline,” mentioned Edward Buthusiem, a managing director in BRG’s Well being Analytics apply. “Along with her spectacular educational background and over a decade of expertise working with the pharmaceutical business, she excels at sourcing viable, high-grade information to evaluate the protection of medicines. Her work is pivotal to core pharmaceutical analysis processes—from the event of a drug to scientific trials to its widespread launch—and our purchasers will enormously profit from her skills.”
Dr. Cheng has collected and utilized information from scientific trials, administrative insurance coverage claims, digital medical information, site- and panel-based medical chart critiques, affected person registries, giant affected person and doctor surveys and longitudinal observational research. She has carried out research in additional than 10 nations and printed her analysis in quite a few medical journals.
Earlier than her foray into well being care consulting, Dr. Cheng served as a analysis scientist at Columbia College and as a biostatistician within the Medical Trials Community of the Nationwide Institute on Drug Abuse. She earned her Ph.D. and MPH in epidemiology from Columbia College Mailman College of Public Well being.
Dr. Cheng commented, “I’m excited to be part of BRG’s well being care apply and to hitch a group of main consultants and famend researchers within the discipline. I look ahead to leveraging our deep understanding of HEOR and epidemiology and superior analytics to assist our purchasers’ merchandise throughout their lifecycles.”
SOURCE: BRG
[ad_2]
